{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:42:27Z","timestamp":1792669347680,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Graduate Scholarship Program","award":["T\u00dcB\u0130TAK BIDEB-2210A"],"award-info":[{"award-number":["T\u00dcB\u0130TAK BIDEB-2210A"]}]},{"name":"the Scientific Research Projects Coordination Unit of Hatay Mustafa Kemal University","award":["22.YL.030"],"award-info":[{"award-number":["22.YL.030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12965-7","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:10:27Z","timestamp":1792667427000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Are adropin gene expression levels a precursor to type 2 diabetes mellitus in prediabetic patients?"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2609-7755","authenticated-orcid":false,"given":"Zeynep","family":"Y\u00fcrekli-Sarar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1704-1370","authenticated-orcid":false,"given":"Meral","family":"Urhan-K\u00fc\u00e7\u00fck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edip","family":"U\u00e7ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4672-2960","authenticated-orcid":false,"given":"G\u00fclay","family":"G\u00fclbol-Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3550-1326","authenticated-orcid":false,"given":"Emre","family":"Dirican","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8176-0295","authenticated-orcid":false,"given":"Se\u00e7kin","family":"Boz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"12965_CR1","unstructured":"American Diabetes Association (2021) ;44(Supplement_1):S15-S33"},{"issue":"14","key":"12965_CR2","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jama.2023.4063","volume":"329","author":"JB Echouffo-Tcheugui","year":"2023","unstructured":"Echouffo-Tcheugui JB, Perreault L, Ji L, Dagogo-Jack S (2023) Diagnosis and management of prediabetes: a review. JAMA 329(14):1206\u20131216","journal-title":"JAMA"},{"issue":"2","key":"12965_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/1570161117666190405165911","volume":"18","author":"D Lovic","year":"2020","unstructured":"Lovic D, Piperidou A, Zografou I, Grassos H, Pittaras A, Manolis A (2020) The growing epidemic of diabetes mellitus. Curr Vasc Pharmacol 18(2):104\u2013109","journal-title":"Curr Vasc Pharmacol"},{"issue":"3","key":"12965_CR4","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3390\/ijms26031094","volume":"26","author":"E M\u0142ynarska","year":"2025","unstructured":"M\u0142ynarska E, Czarnik W, Dzie\u017ca N, J\u0119draszak W, Majchrowicz G, Prusinowski F et al (2025) Type 2 diabetes mellitus: new pathogenetic mechanisms, treatment and the most important complications. Int J Mol Sci 26(3):1094","journal-title":"Int J Mol Sci"},{"key":"12965_CR5","doi-asserted-by":"publisher","first-page":"1143067","DOI":"10.3389\/fendo.2023.1143067","volume":"14","author":"A Mansour","year":"2023","unstructured":"Mansour A, Mousa M, Abdelmannan D, Tay G, Hassoun A, Alsafar H (2023) Microvascular and macrovascular complications of type 2 diabetes mellitus: Exome wide association analyses. Front Endocrinol 14:1143067","journal-title":"Front Endocrinol"},{"issue":"4","key":"12965_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/1573403X1604201229115531","volume":"16","author":"P Farmaki","year":"2020","unstructured":"Farmaki P, Damaskos C, Garmpis N, Garmpi A, Savvanis S, Diamantis E (2020) Complications of the type 2 diabetes mellitus. Curr Cardiol Rev 16(4):249\u2013251","journal-title":"Curr Cardiol Rev"},{"issue":"7","key":"12965_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41574-025-01114-y","volume":"21","author":"D Accili","year":"2025","unstructured":"Accili D, Deng Z, Liu Q (2025) Insulin resistance in type 2 diabetes mellitus. Nat Reviews Endocrinol 21(7):413\u2013426","journal-title":"Nat Reviews Endocrinol"},{"issue":"1","key":"12965_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4093\/dmj.2024.0796","volume":"49","author":"IR Park","year":"2025","unstructured":"Park IR, Chung YG, Won KC (2025) Overcoming \u03b2-cell dysfunction in type 2 diabetes mellitus: CD36 inhibition and antioxidant system. Diabetes Metabolism J 49(1):1","journal-title":"Diabetes Metabolism J"},{"issue":"6","key":"12965_CR9","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.cmet.2008.10.011","volume":"8","author":"KG Kumar","year":"2008","unstructured":"Kumar KG, Trevaskis JL, Lam DD, Sutton GM, Koza RA, Chouljenko VN et al (2008) Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metabol 8(6):468\u2013481","journal-title":"Cell Metabol"},{"key":"12965_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.peptides.2014.03.021","volume":"56","author":"S Aydin","year":"2014","unstructured":"Aydin S (2014) Three new players in energy regulation: preptin, adropin and irisin. Peptides 56:94\u2013110","journal-title":"Peptides"},{"key":"12965_CR11","doi-asserted-by":"publisher","first-page":"1482308","DOI":"10.3389\/fimmu.2025.1482308","volume":"16","author":"J Wang","year":"2025","unstructured":"Wang J, Ding N, Chen C, Gu S, Liu J, Wang Y et al (2025) Adropin: a key player in immune cell homeostasis and regulation of inflammation in several diseases. Front Immunol 16:1482308","journal-title":"Front Immunol"},{"issue":"3","key":"12965_CR12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3390\/molecules25030549","volume":"25","author":"M Jasaszwili","year":"2020","unstructured":"Jasaszwili M, Billert M, Strowski MZ, Nowak KW, Skrzypski M (2020) Adropin as a fat-burning hormone with multiple functions\u2014Review of a decade of research. Molecules 25(3):549","journal-title":"Molecules"},{"issue":"6","key":"12965_CR13","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.fshw.2022.06.002","volume":"11","author":"H Zhang","year":"2022","unstructured":"Zhang H, Chen N (2022) Adropin as an indicator of T2DM and its complications. Food Sci Hum Wellness 11(6):1455\u20131463","journal-title":"Food Sci Hum Wellness"},{"issue":"4","key":"12965_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.numecd.2005.12.007","volume":"16","author":"G Valerio","year":"2006","unstructured":"Valerio G, Licenziati M, Iannuzzi A, Franzese A, Siani P, Riccardi G et al (2006) Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr metabolism Cardiovasc Dis 16(4):279\u2013284","journal-title":"Nutr metabolism Cardiovasc Dis"},{"key":"12965_CR15","doi-asserted-by":"publisher","first-page":"1396022","DOI":"10.3389\/fendo.2024.1396022","volume":"15","author":"Y-Y Zhang","year":"2024","unstructured":"Zhang Y-Y, Li Y-J, Xue C-D, Li S, Gao Z-N, Qin K-R (2024) Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms. Front Endocrinol 15:1396022","journal-title":"Front Endocrinol"},{"issue":"17","key":"12965_CR16","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.3390\/ijms21176275","volume":"21","author":"U Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB et al (2020) Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 21(17):6275","journal-title":"Int J Mol Sci"},{"issue":"1","key":"12965_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1146\/annurev-publhealth-090419-102644","volume":"42","author":"JB Echouffo-Tcheugui","year":"2021","unstructured":"Echouffo-Tcheugui JB, Selvin E (2021) Prediabetes and what it means: the epidemiological evidence. Annu Rev Public Health 42(1):59\u201377","journal-title":"Annu Rev Public Health"},{"issue":"1","key":"12965_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/epirev\/mxq020","volume":"33","author":"JB Echouffo-Tcheugui","year":"2011","unstructured":"Echouffo-Tcheugui JB, Ali MK, Griffin SJ, Narayan KV (2011) Screening for type 2 diabetes and dysglycemia. Epidemiol Rev 33(1):63\u201387","journal-title":"Epidemiol Rev"},{"issue":"11","key":"12965_CR19","doi-asserted-by":"publisher","first-page":"861","DOI":"10.7326\/M15-2345","volume":"163","author":"AL Siu","year":"2015","unstructured":"Siu AL, Force* UPST (2015) Screening for abnormal blood glucose and type 2 diabetes mellitus: US Preventive Services Task Force recommendation statement. Ann Intern Med 163(11):861\u2013868","journal-title":"Ann Intern Med"},{"issue":"6","key":"12965_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"Diabetes Prevention Program Research Group","year":"2002","unstructured":"Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346(6):393\u2013403","journal-title":"N Engl J Med"},{"issue":"4","key":"12965_CR21","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2337\/diacare.20.4.537","volume":"20","author":"X-R Pan","year":"1997","unstructured":"Pan X-R, Li G-w, Hu Y-H, Wang J-X, Yang W-Y, An Z-X et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20(4):537\u2013544","journal-title":"Diabetes Care"},{"issue":"2","key":"12965_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","volume":"49","author":"A Ramachandran","year":"2006","unstructured":"Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar A, Vijay V et al (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49(2):289\u2013297","journal-title":"Diabetologia"},{"issue":"5","key":"12965_CR23","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1210\/jc.2015-4202","volume":"101","author":"D Tripathy","year":"2016","unstructured":"Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC et al (2016) Diabetes incidence and glucose tolerance after termination of pioglitazone therapy: results from ACT NOW. J Clin Endocrinol Metabolism 101(5):2056\u20132062","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"8","key":"12965_CR24","doi-asserted-by":"publisher","first-page":"10056","DOI":"10.1096\/fj.202000115RR","volume":"34","author":"X Chen","year":"2020","unstructured":"Chen X, Chen S, Shen T, Yang W, Chen Q, Zhang P et al (2020) Adropin regulates hepatic glucose production via PP2A\/AMPK pathway in insulin-resistant hepatocytes. FASEB J 34(8):10056\u201310072","journal-title":"FASEB J"},{"issue":"7","key":"12965_CR25","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1136\/jim-2021-001796","volume":"69","author":"H Erman","year":"2021","unstructured":"Erman H, Ozdemir A, Sitar ME, Cetin SI, Boyuk B (2021) Role of serum adropin measurement in the assessment of insulin resistance in obesity. J Investig Med 69(7):1318\u20131323","journal-title":"J Investig Med"},{"issue":"9","key":"12965_CR26","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3390\/biom10091304","volume":"10","author":"K Komosinska-Vassev","year":"2020","unstructured":"Komosinska-Vassev K, Gala O, Olczyk K, Jura-P\u00f3\u0142torak A, Olczyk P (2020) The usefulness of diagnostic panels based on circulating adipocytokines\/regulatory peptides, renal function tests, insulin resistance indicators and lipid-carbohydrate metabolism parameters in diagnosis and prognosis of type 2 diabetes mellitus with obesity. Biomolecules 10(9):1304","journal-title":"Biomolecules"},{"issue":"2","key":"12965_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/biomedicines11020457","volume":"11","author":"AA Berezin","year":"2023","unstructured":"Berezin AA, Obradovic Z, Fushtey IM, Berezina TA, Novikov EV, Schmidbauer L et al (2023) The impact of SGLT2 inhibitor dapagliflozin on adropin serum levels in men and women with type 2 diabetes mellitus and chronic heart failure. Biomedicines 11(2):457","journal-title":"Biomedicines"},{"key":"12965_CR28","doi-asserted-by":"publisher","first-page":"696163","DOI":"10.3389\/fphys.2021.696163","volume":"12","author":"N Li","year":"2021","unstructured":"Li N, Xie G, Zhou B, Qu A, Meng H, Liu J et al (2021) Serum adropin as a potential biomarker for predicting the development of type 2 diabetes mellitus in individuals with metabolic dysfunction-associated fatty liver disease. Front Physiol 12:696163","journal-title":"Front Physiol"},{"issue":"3","key":"12965_CR29","first-page":"402","volume":"13","author":"S Banu","year":"2014","unstructured":"Banu S, Jabir N R, Manjunath C, Firoz N, A Kamal C, Khan MS (2014) Comparative study of non-high density lipoproteins cholesterol level and lipid profile in pre-diabetic and diabetic patients. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS &. Neurol Disorders) 13(3):402\u2013407","journal-title":"Neurol Disorders)"},{"issue":"1","key":"12965_CR30","first-page":"277","volume":"77","author":"O Jasim","year":"2022","unstructured":"Jasim O, Mahmood M, Ad\u2019hiah A (2022) Significance of lipid profile parameters in predicting pre-diabetes. Arch Razi Inst 77(1):277","journal-title":"Arch Razi Inst"},{"issue":"11","key":"12965_CR31","doi-asserted-by":"publisher","first-page":"108869","DOI":"10.1016\/j.jdiacomp.2024.108869","volume":"38","author":"R Dimova","year":"2024","unstructured":"Dimova R, Chakarova N, Serdarova M, Tankova T (2024) Lipid profile is similar in both subjects with high 1-hour postload glucose and 2-hour postload glucose and is related to cardio-metabolic profile in prediabetes. J Diabetes Complicat 38(11):108869","journal-title":"J Diabetes Complicat"},{"issue":"1","key":"12965_CR32","doi-asserted-by":"publisher","first-page":"14691","DOI":"10.1038\/srep14691","volume":"5","author":"AA Butler","year":"2015","unstructured":"Butler AA, St-Onge M-P, Siebert EA, Medici V, Stanhope KL, Havel PJ (2015) Differential responses of plasma adropin concentrations to dietary glucose or fructose consumption in humans. Sci Rep 5(1):14691","journal-title":"Sci Rep"},{"issue":"2","key":"12965_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/life12020169","volume":"12","author":"P Simac","year":"2022","unstructured":"Simac P, Perkovic D, Bozic I, Bilopavlovic N, Martinovic D, Bozic J (2022) Serum adropin levels in patients with rheumatoid arthritis. Life 12(2):169","journal-title":"Life"},{"issue":"1","key":"12965_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12902-023-01327-0","volume":"23","author":"S Soltani","year":"2023","unstructured":"Soltani S, Beigrezaei S, Malekahmadi M, Clark CC, Abdollahi S (2023) Circulating levels of adropin and diabetes: a systematic review and meta-analysis of observational studies. BMC Endocr disorders 23(1):73","journal-title":"BMC Endocr disorders"},{"key":"12965_CR35","first-page":"44","volume":"5","author":"A Hosseini","year":"2016","unstructured":"Hosseini A, Shanaki M, Emamgholipour S, Nakhjavani M, Razi F, Golmohammadi T (2016) Elevated serum levels of adropin in patients with type 2 diabetes mellitus and its association with insulin resistance. J Biol Today\u2019s World 5:44\u201349","journal-title":"J Biol Today\u2019s World"},{"key":"12965_CR36","doi-asserted-by":"crossref","unstructured":"Ugur K, Oz B, Ozkan Y, Sener SY, Orhan B, Aydin S (2015) Microalbuminuria by concentration serum and urine levels of adropin in patients with type 2 diabetes mellitus. Endocrine Abstracts. 37. Bioscientifica","DOI":"10.1530\/endoabs.37.EP446"},{"key":"12965_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.molmet.2017.12.002","volume":"8","author":"S Ghoshal","year":"2018","unstructured":"Ghoshal S, Stevens JR, Billon C, Girardet C, Sitaula S, Leon AS et al (2018) Adropin: An endocrine link between the biological clock and cholesterol homeostasis. Mol metabolism 8:51\u201364","journal-title":"Mol metabolism"},{"issue":"6","key":"12965_CR38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/CS20110386","volume":"122","author":"B Viollet","year":"2012","unstructured":"Viollet B, Guigas B, Garcia NS, Leclerc J, Foretz M, Andreelli F (2012) Cellular and molecular mechanisms of metformin: an overview. Clin Sci 122(6):253\u2013270","journal-title":"Clin Sci"},{"issue":"2","key":"12965_CR39","first-page":"344","volume":"59","author":"T Ti\u010dinovi\u0107 Kurir","year":"2020","unstructured":"Ti\u010dinovi\u0107 Kurir T, Mili\u010devi\u0107 T, Novak A, Vilovi\u0107 M, Bo\u017ei\u0107 J (2020) Adropin\u2013potential link in cardiovascular protection for obese male type 2 diabetes mellitus patients treated with liraglutide. Acta Clin Croatica 59(2):344\u2013350","journal-title":"Acta Clin Croatica"},{"issue":"3","key":"12965_CR40","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/medicina61030399","volume":"61","author":"T Akbulut","year":"2025","unstructured":"Akbulut T, Cinar V, Avcu EC, Yasul Y, Aydemir \u0130, Kuloglu T et al (2025) The regulatory effects of exercise and metformin on biomarkers in obesity: A focus on uric acid, irisin, adiponutrin, adropin, and copeptin. Medicina 61(3):399","journal-title":"Medicina"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12965-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12965-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12965-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:10:30Z","timestamp":1792667430000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12965-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12965"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12965-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1784"}}